Skip to main content

Table 3 Proportion of responders to treatment

From: Topical applications of allogeneic adipose-derived mesenchymal stem cells ameliorate the canine keratoconjunctivitis sicca

Group

N

3rd week

6th week

9th week

Naïve

21

28.6%

47.6%

57.1%

Refractory

23

30.4%

47.8%

56.5%

  1. Patients with STT-1 values increased more than 5 mm/min compared to pre-trial STT-1 values were defined as responders